#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Inflammatory myofibroblastic tumour Graft versus host disease Arteriosclerosis Neurodermatitis PIK3CA-activated mutation Sarcoma Bile acid synthesis disorder B-cell type acute leukaemia Ovarian cancer Desmoplastic small round cell tumour Kidney transplant rejection Fallopian tube cancer Angelman's syndrome Renal disorder Carcinoid syndrome More trials…

    Learn about Rare Diseases

    Vascular malformation – Trials in Disease Osteosarcoma metastatic – Trials in Disease Osteosarcoma metastatic – Treatment Mantle cell lymphoma stage II – Diagnostics Synovial sarcoma recurrent Sjogren’s syndrome – Diagnostics Leukoencephalopathy – Diagnostics Pituitary-dependent Cushing’s syndrome – Life with Disease Hyperoxaluria – Treatment Factor IX deficiency More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    CILOSTAZOL Afimetoran Besilate Dihydrate Batoprotafib Patiromer Iodine (123I) Iobenguane Lutetium (177Lu) Edotreotide Lorlatinib HLX43 Ocrelizumab Naloxegol Oxalate Thymalfasin Ht-29-B Empagliflozin Basiliximab Amniotic Membrane, Human Daplusiran Tofacitinib Citrate Resmetirom AMO959 Florquinitau (18F) More therapies…

    Learn about Your Condition

    Breast angiosarcoma metastatic Heart disease congenital Eyelid ptosis Metabolic surgery Fibromyalgia Vitiligo Osteoarthritis Myopia Netherton's syndrome Renal failure Myocarditis post infection Spinal muscular atrophy Leukocyte adhesion deficiency Iron overload Hypoxia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Cervix carcinoma

  • Study of TG4001 and Avelumab for Patients with Advanced HPV-16 Positive Cancers

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Anal cancer
    • Vaginal cancer
    • Cervix carcinoma
    Investigated Drugs:
    • Tipapkinogene Sovacivec
    • Avelumab
    France Spain

  • Study Comparing Tisotumab Vedotin with Chemotherapy for Patients with Recurrent or Metastatic Cervical Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Cervix carcinoma
    Investigated Drugs:
    • Dextran 70
    • Tisotumab Vedotin
    • Hypromellose
    Austria Belgium Czechia Finland France Germany +7

  • Study on the Safety and Effectiveness of SKB264 and Pembrolizumab for Patients with Cervical, Urothelial, Ovarian, or Prostate Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Endometrial cancer
    • Cervix carcinoma
    • Ovarian cancer
    Investigated Drugs:
    • Anhydrous Caffeine
    • Paracetamol Dc
    • Paracetamol Ph. Eur.
    Belgium France Poland Spain

  • Study on Atezolizumab, Bevacizumab, and Chemotherapy for Patients with Advanced Cervical Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Cervix carcinoma
    Investigated Drugs:
    • Atezolizumab
    • Bevacizumab
    France Germany Italy Norway Spain Sweden
Previous Page
1 … 4 5 6

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!